Pathological Response and Gene Expression in Rectal Cancer Neoadjuvant Therapy

Abstract

Rectal Adenocarcinoma (RA) represents more than 90% of rectal tumors, with high global incidence and mortality rates. Treatment includes neoadjuvant therapy